PTU-110 Long-Term Safety of Teduglutide Treatment for Patients with Intestinal Failure Associated with Short Bowel Syndrome: Pooled Data from 4 Clinical Trials

IntroductionTeduglutide (TED) is indicated for the treatment of adults with intestinal failure associated with short bowel syndrome (SBS-IF) who are dependent on parenteral support (PS). In phase III randomised placebo-controlled trials, TED significantly reduced PS volume requirements and number of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gut 2016-06, Vol.65 (Suppl 1), p.A109-A110
Hauptverfasser:	Gabe, SM, Pape, U-F, Delmaestro, E, Li, B, Youssef, NN, Seidner, D
Format:	Artikel
Sprache:	eng
Schlagworte:	Abdomen Adenocarcinoma Chemotherapy Clinical trials Diarrhea Distension Headache Hodgkin's lymphoma Hypersensitivity Intestine Lung cancer Metastases Metastasis Nausea Pain Patients Respiratory tract diseases Safety Sepsis Short bowel syndrome Squamous cell carcinoma Urinary tract Vomiting
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!